Hussnain Mirza, MD, MBA

Double board certified in Neonatal Perinatal Medicine & General Pediatrics, Fellow of the College of Physicians & Surgeons and Royal College of Pediatrics & Child Health, London. UK. MBA from University of Central Florida (UCF, College of Business) and certified in Artificial Intelligence Applications in Healthcare from the UCF College of Global Health & Innovation. Took leadership roles in clinical neonatology, graduate medical education (GME) and clinical research. Currently serves as Program Director for the Neonatal–Perinatal Medicine Fellowship at AdventHealth for Children in Orlando. My research interests include pulmonary vascular disease of prematurity, hypoxic respiratory failure, bronchopulmonary dysplasia (BPD), neonatal hemodynamics, and patent ductus arteriosus (PDA).
An expert provider of advanced neonatal life support, with proficiency in high-frequency ventilation, neonatal ECMO, point-of-care ultrasound (POCUS), and Targeted Neonatal Echocardiography (TnECHO). Scholarly contributions include multiple book chapters and peer-reviewed publications in leading journals, as well as service as principal investigator on externally funded research projects. Recently completed a randomized clinical trial evaluating early pulmonary hypertension in preterm infants (ClinicalTrials.gov Identifier: NCT03576885). Actively engaged in digital health and innovation initiatives through partnerships with AdventHealth Clinical Pilots and OpenAI.
Financial relationships
-
Type of financial relationship:There are no financial relationships to disclose.Date added:04/21/2026Date updated:04/21/2026

Facebook
X
LinkedIn
Forward